Fortunately, in this study, we discovered that baicalin interferes with the PKC-MAPK pathway and has the potential to treat the inflammation-induced apoptosis of peritonitis caused by GPS infection in PPMC cells, suggesting that baicalin has the potential to be a candidate drug for the treatment of peritonitis caused by GPS infection. This evidence concerns the gene PRRT2 and peritonitis.